The utility of fine-needle aspiration: how FNA has affected our musculoskeletal oncology practice.
Autor: | Voskuil RT; Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio., Mayerson JL; Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address: Joel.Mayerson@osumc.edu., Scharschmidt TJ; Department of Orthopaedics, The Ohio State University Wexner Medical Center, Columbus, Ohio. |
---|---|
Jazyk: | angličtina |
Zdroj: | Journal of the American Society of Cytopathology [J Am Soc Cytopathol] 2020 Nov - Dec; Vol. 9 (6), pp. 596-601. Date of Electronic Publication: 2020 Jul 15. |
DOI: | 10.1016/j.jasc.2020.06.006 |
Abstrakt: | Fine-needle aspiration (FNA) has been a widely accepted practice in the diagnosis of head and neck, thyroid, lung, pancreas, and many other visceral sites. This has not been the case with the diagnosis of primary bone and soft tissue lesions. FNA has been an important part of our orthopaedic oncology practice for 18 years. Our ability to efficiently and effectively care for patients dramatically improved when FNA became an option for obtaining a tissue diagnosis. We discuss the advantages and disadvantages of a pathologist-driven FNA service in orthopaedic oncology. (Copyright © 2020 American Society of Cytopathology. Published by Elsevier Inc. All rights reserved.) |
Databáze: | MEDLINE |
Externí odkaz: |